M. Wasilewski

Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis.

D. Johns, M. Wasilewski, G. Sides, 1999, The Journal of antimicrobial chemotherapy.

Daptomycin: a novel agent for Gram-positive infections.

G. Drusano, M. Zeckel, C. Carini, 1999, Expert opinion on investigational drugs.

Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections.

M. Wasilewski, G. Sides, J. Stotka, 2000, The Journal of antimicrobial chemotherapy.

Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trial.

I. Krägeloh-Mann, R. Giugliani, N. Sakai, 2020, Molecular genetics and metabolism.

Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial

M. Wasilewski, L. Dunbar, T. McClure, 2011, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic Modeling of Intrathecally Administered Recombinant Human Arylsulfatase A (TAK‐611) in Children With Metachromatic Leukodystrophy

S. Troy, J. Beusmans, M. Wasilewski, 2019, Clinical pharmacology and therapeutics.

Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1/2 study

C. Krarup, S. Groeschel, I. Krägeloh-Mann, 2020, Annals of clinical and translational neurology.

Intrathecal delivery of recombinant human arylsulfatase A in children with late-infantile metachromatic leukodystrophy: an update following extended treatment

D. Kerr, R. Giugliani, J. Riethmüller, 2017 .